TR200100054T2 - Paroksetin metansülfonat - Google Patents

Paroksetin metansülfonat

Info

Publication number
TR200100054T2
TR200100054T2 TR2001/00054T TR200100054T TR200100054T2 TR 200100054 T2 TR200100054 T2 TR 200100054T2 TR 2001/00054 T TR2001/00054 T TR 2001/00054T TR 200100054 T TR200100054 T TR 200100054T TR 200100054 T2 TR200100054 T2 TR 200100054T2
Authority
TR
Turkey
Prior art keywords
paroxetine methanesulfonate
paroxetine
methanesulfonate
therapy
pharmaceutical compositions
Prior art date
Application number
TR2001/00054T
Other languages
English (en)
Inventor
Victor Jacewicz Witold
William Michael Urquhart John
Andrew Craig Simon
David Jones Alan
Keeffe Deirdre O
Ward Neal
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200100054(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9814316.7A external-priority patent/GB9814316D0/en
Priority claimed from GBGB9821732.6A external-priority patent/GB9821732D0/en
Priority claimed from GBGB9902935.7A external-priority patent/GB9902935D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200100054T2 publication Critical patent/TR200100054T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Paroksetin metansülfonat, hazirlama prosesleri, bunu içeren farmasötik terkipler ve terapide kullanimi açiklanmaktadir.
TR2001/00054T 1998-07-02 1999-04-23 Paroksetin metansülfonat TR200100054T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
GBGB9821732.6A GB9821732D0 (en) 1998-10-06 1998-10-06 Novel compound
GBGB9902935.7A GB9902935D0 (en) 1999-02-10 1999-02-10 Novel compound

Publications (1)

Publication Number Publication Date
TR200100054T2 true TR200100054T2 (tr) 2001-06-21

Family

ID=27269380

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00054T TR200100054T2 (tr) 1998-07-02 1999-04-23 Paroksetin metansülfonat

Country Status (35)

Country Link
US (4) US6063927A (tr)
EP (5) EP1089996B1 (tr)
JP (1) JP2002519422A (tr)
KR (1) KR20010053336A (tr)
CN (1) CN1127502C (tr)
AR (2) AR011759A1 (tr)
AT (4) ATE195121T1 (tr)
AU (4) AU732211C (tr)
BE (3) BE1011664A6 (tr)
BR (1) BR9911682A (tr)
CA (1) CA2269999A1 (tr)
CH (1) CH689805A8 (tr)
DE (5) DE69911774T2 (tr)
DK (7) DK1089996T3 (tr)
ES (4) ES2158778B1 (tr)
FI (2) FI112077B (tr)
FR (2) FR2780728B1 (tr)
GB (5) GB2367003A (tr)
GR (3) GR990100140A (tr)
HK (1) HK1037877A1 (tr)
HU (1) HUP0102334A3 (tr)
IE (5) IE20000633A1 (tr)
IL (1) IL140628A (tr)
IT (1) IT1312540B1 (tr)
LU (1) LU90388B1 (tr)
NL (4) NL1011875C2 (tr)
NO (1) NO319030B1 (tr)
NZ (1) NZ509180A (tr)
PL (1) PL345214A1 (tr)
PT (4) PT1020464E (tr)
SE (1) SE9901462A0 (tr)
SI (3) SI1020464T1 (tr)
SK (1) SK20262000A3 (tr)
TR (1) TR200100054T2 (tr)
WO (1) WO2000001694A1 (tr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
BR9807625A (pt) * 1997-02-27 2000-02-22 Ajinomoto Kk Aparelho e processo para cristalização.
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040028582A1 (en) * 1999-03-10 2004-02-12 Smithkline Beecham Corporation Crystallization process for producing fine crystal products
USPP12225P2 (en) 1999-06-01 2001-11-27 Florfis Ag Geranium plant named ‘Fislamda’
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6645523B2 (en) * 2000-08-28 2003-11-11 Synthon Bct Technologies, Llc Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1412350A1 (en) * 2001-08-02 2004-04-28 Spurcourt Limited Paroxetine isethionate salt, process of preparation and use in the treatment of depression
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
NZ562203A (en) 2005-04-07 2010-09-30 Xy Llc Flow path conditioner system utilising an antimicrobial aqueous solvent composition
AU2006315684A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US8722884B2 (en) * 2005-12-01 2014-05-13 Verastem, Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
AU2008226645B2 (en) * 2007-03-09 2012-09-20 Novartis Ag Salts of 3- (1H-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one
US8119688B2 (en) * 2007-09-19 2012-02-21 Xy, Llc Differential evaporation potentiated disinfectant system
US20100249166A1 (en) * 2007-09-19 2010-09-30 Xy, Inc. Differential evaporation potentiated disinfectant system
FR2926552B1 (fr) * 2008-01-23 2010-03-26 Biocodex Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11111373B2 (en) 2018-12-05 2021-09-07 Chi Mei Corporation Polymethacrylate composition and optical device made therefrom, and display apparatus

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE99678C (tr) *
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223430B1 (en) * 1985-10-21 1991-02-27 Honda Giken Kogyo Kabushiki Kaisha Method for controlling the solenoid current of a solenoid valve which controls the amount of suction of air in an internal combustion engine
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
JPS63141967A (ja) * 1986-11-21 1988-06-14 エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド 抗アレルギー薬として有用な１−アリールオキシー４−［（４−アリール）−１−ピペラジニル］−２−ブタノール
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
US5371092A (en) * 1990-11-24 1994-12-06 Beecham Group, P.L.C. Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) * 1992-11-30 1998-07-09 東レ株式会社 Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
US5546683A (en) * 1993-09-29 1996-08-20 Clark; George J. Bucket attachment device with remote controlled retractable pins
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5668134A (en) * 1994-01-28 1997-09-16 G. D. Searle & Co. Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
EP0828735A1 (en) * 1995-05-17 1998-03-18 Novo Nordisk A/S Process for preparing 4-aryl-piperidine derivatives
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
AU701386B2 (en) * 1995-10-31 1999-01-28 Merck & Co., Inc. Process for preparing substituted azetidinones
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) * 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP0812827B1 (en) * 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
IL137684A0 (en) * 1998-02-06 2001-10-31 Smithkline Beechmam Plc Salts of paroxetine
EA200000946A1 (ru) * 1998-03-16 2001-02-26 Смитклайн Бичам Плс Кристаллическая форма пароксетина
IL138920A0 (en) * 1998-04-09 2001-11-25 Smithkline Beecham Plc Paroxetine maleate
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat

Also Published As

Publication number Publication date
DK199900234U1 (da) 2000-12-22
HK1037877A1 (en) 2002-02-22
BR9911682A (pt) 2001-12-26
GR990100140A (el) 2000-03-31
IT1312540B1 (it) 2002-04-22
LU90388B1 (fr) 2001-01-29
GB9909505D0 (en) 1999-06-23
IL140628A (en) 2004-06-20
HUP0102334A3 (en) 2003-12-29
GB0026487D0 (en) 2000-12-13
EP1020463A1 (en) 2000-07-19
FR2802098A1 (fr) 2001-06-15
ATE202777T1 (de) 2001-07-15
DK199900176U3 (da) 1999-08-13
BE1012420A6 (fr) 2000-10-03
GB2336364A (en) 1999-10-20
EP1020464A1 (en) 2000-07-19
US20020035130A1 (en) 2002-03-21
IE990344A1 (en) 2000-05-03
ITMI990866A1 (it) 2000-10-23
NL1012272C1 (nl) 1999-07-12
SI1089996T1 (en) 2004-04-30
GR3034328T3 (en) 2000-12-29
GR3036208T3 (en) 2001-10-31
CN1315949A (zh) 2001-10-03
CN1127502C (zh) 2003-11-12
AU713131B3 (en) 1999-11-25
DK199900554A (da) 2000-01-03
IES81166B2 (en) 2000-05-31
GB2367003A (en) 2002-03-27
PT970955E (pt) 2000-11-30
DK1020464T3 (da) 2001-09-24
PT102291B (pt) 2002-07-31
NO319030B1 (no) 2005-06-06
US6063927A (en) 2000-05-16
DK199900234U4 (da) 2000-12-22
NL1012271C2 (nl) 1999-09-23
DK200000390U1 (da) 2000-12-27
NL1012271A1 (nl) 1999-07-12
PT1089996E (pt) 2004-02-27
FI4209U1 (fi) 1999-11-10
NL1011875C2 (nl) 2000-03-24
ES2149044T3 (es) 2000-10-16
FR2780728A1 (fr) 2000-01-07
HUP0102334A2 (hu) 2002-05-29
AT3185U3 (de) 2000-01-25
JP2002519422A (ja) 2002-07-02
SI0970955T1 (en) 2001-02-28
DE69900007T2 (de) 2001-06-07
US20010023253A1 (en) 2001-09-20
GB9920332D0 (en) 1999-11-03
EP1288214A1 (en) 2003-03-05
ATE195121T1 (de) 2000-08-15
CH689805A8 (fr) 2000-02-29
IL140628A0 (en) 2002-02-10
BE1012403A5 (fr) 2000-10-03
DE60000003T2 (de) 2002-03-21
SK20262000A3 (sk) 2001-07-10
AU713877B3 (en) 1999-12-09
DE69900007D1 (de) 2000-09-07
IE20000633A1 (en) 2001-10-17
FI990922A (fi) 2000-01-03
PT1020464E (pt) 2001-10-30
BE1011664A6 (fr) 1999-11-09
EP1089996A1 (en) 2001-04-11
DE69911774D1 (de) 2003-11-06
IES20000893A2 (en) 2001-05-30
ES2157881T3 (es) 2001-09-01
FI990922A0 (fi) 1999-04-23
AU732211B2 (en) 2001-04-12
GB2339428A (en) 2000-01-26
IES20000894A2 (en) 2001-05-30
CA2269999A1 (en) 2000-01-02
AR018197A1 (es) 2001-10-31
DE69911774T2 (de) 2004-08-05
US20020193406A1 (en) 2002-12-19
EP0970955B1 (en) 2000-08-02
EP1020464B1 (en) 2001-07-04
NL1011874C1 (nl) 1999-07-12
NZ509180A (en) 2001-06-29
WO2000001694A1 (en) 2000-01-13
PL345214A1 (en) 2001-12-03
EP0970955A1 (en) 2000-01-12
KR20010053336A (ko) 2001-06-25
NO991944D0 (no) 1999-04-23
GB2336364B (en) 2000-05-10
DE29907248U1 (de) 1999-09-09
FIU990190U0 (fi) 1999-04-23
GB2352395B (en) 2004-02-11
AU732211C (en) 2004-05-06
ES2158778A1 (es) 2001-09-01
DE60000003D1 (de) 2001-08-09
ES2209428T3 (es) 2004-06-16
ES2158778B1 (es) 2002-03-16
SE9901462A0 (sv) 2000-01-03
DK1089996T3 (da) 2004-02-09
NO991944L (no) 2000-01-03
CH689805A5 (fr) 1999-11-30
GR1003350B (el) 2000-03-29
FR2780728B1 (fr) 2001-02-16
SE9901462D0 (sv) 1999-04-23
NL1011875A1 (nl) 2000-01-07
ATE251155T1 (de) 2003-10-15
AU3619199A (en) 2000-01-24
PT102291A (pt) 2000-05-31
SI1020464T1 (en) 2001-12-31
IES990343A2 (en) 2000-01-02
DE19918588A1 (de) 2000-01-27
GB0119695D0 (en) 2001-10-03
GB0216752D0 (en) 2002-08-28
EP1089996B1 (en) 2003-10-01
FI112077B (fi) 2003-10-31
AU2392899A (en) 2000-01-20
SE9901462L (tr)
AR011759A1 (es) 2000-09-13
GB2352395A (en) 2001-01-31
GB2377637A (en) 2003-01-22
DK0970955T3 (da) 2000-10-09
AT3185U2 (de) 1999-11-25

Similar Documents

Publication Publication Date Title
TR200100054T2 (tr) Paroksetin metansülfonat
ATE231872T1 (de) Thiazolopyrimidinderivate
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
SE9704546D0 (sv) Novel compounds
TR199802423T2 (tr) Konsantre antikor terkibi.
NO20010028D0 (no) Benzimidazoler, deres fremstilling og anvendelse som legemidler
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
NO20006138D0 (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
AP1703A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
SE9802937D0 (sv) Novel compounds
NO20022022D0 (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
AP2000002017A0 (en) Salts of paroxetine.
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
ATE382363T1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum
DK1072266T3 (da) Thienylazolylalkoxyethanaminer, deres fremstilling og deres anvendelse som lægemidler
AU2002333339A1 (en) Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
EE200200229A (et) Diarüülenüünid, kompositsioon ja farmatseutiline kompositsioon